| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 1.213 | 34.563 | 78.062 | 138.552 |
| Total Income - EUR | - | - | - | - | - | - | 1.213 | 34.563 | 78.062 | 138.552 |
| Total Expenses - EUR | - | - | - | - | - | - | 2 | 2.447 | 45.915 | 83.288 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 1.211 | 32.116 | 32.147 | 55.265 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 1.175 | 31.321 | 31.460 | 51.731 |
| Employees | - | - | - | - | - | - | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Melicovici Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 71 | 903 | 26.476 | 146.095 |
| Current Assets | - | - | - | - | - | - | 1.282 | 32.018 | 11.471 | 22.210 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 1.213 | 22.856 | 4.387 | 13.137 |
| Cash | - | - | - | - | - | - | 69 | 9.163 | 7.084 | 9.073 |
| Shareholders Funds | - | - | - | - | - | - | 1.216 | 31.370 | 32.377 | 83.927 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 137 | 1.552 | 5.570 | 85.086 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Melicovici Med S.r.l.